Understanding the Risk Factors for Felty’s Syndrome
Felty’s syndrome, a rare condition associated with rheumatoid arthritis, affects a small portion of the population, specifically between one and three percent of individuals with rheumatoid arthritis. The syndrome is more commonly observed in Caucasian individuals aged 50 to 70, with women being three times more likely to develop it than men. Although Felty’s syndrome is not directly linked to hereditary factors, certain risk factors, such as the HLA-DR4 serotype, may have a genetic component in its development.
Managing Rheumatoid Arthritis to Treat Felty’s Syndrome
Felty’s syndrome is diagnosed based on the presence of an enlarged spleen, an extremely low white blood cell count, and rheumatoid arthritis. While there is no definitive test for this syndrome, focusing on treating rheumatoid arthritis is crucial in managing the disorder. Rheumatoid arthritis is considered a significant contributing factor to Felty’s syndrome. By using anti-inflammatory drugs, the damage caused by the syndrome can be controlled. Additionally, disease-modifying anti-rheumatic drugs (DMARDs) may help reduce joint damage associated with Felty’s syndrome.